Tom, the US market has been hammered. The debate was long to seperate umbilical cord blood from embryonic. Then Pharma sued the privates. In the midst of those lawsuits pharma supported the unrelated cord experts and banks stealing the spotlight in 05'. Politicians were convinced to pour money down the (1 stored for every 10 cord donated) NMDP hole.
The privates were hit hard in the news as greedy operators trying to scare moms into banking their childs cord blood for $2k. All the while NMDP was costing taxpayers upwards of $22.5k to bank just 1 out of 10 (Kurtzberg quoted the NMDP collection fee as $2500/cord). So much for free. Privates hung on waiting for the University funded research to prove that your own stem cells work better than someones donated stem cells. FDA recognized and posted these findings in 09'. That was the same year Matt announced he was building a lab in Vegas but keep in mind prior to that announcement he stated in another PR, "the infrastructure was in place." Then in May 2010 unrelated experts like Kurtzberg's finally admitted private family-related banks are best. Here we are a couple of months into the trillion dollar motor being turned on to run this USA heatlhcare train down the stem cell treatment tracks. Corcell has patent connections with Regenetech and it is connected to HCA; a $40 billion IPO. I hope something comes of that connection. Add to it Dr. O'Neill was the former President of Regenetech and the SEC filings that tell us that multiple labs would be opened to support the HCA biotech business and I can't help but wonder our we the US lab. Tom, HOTI has for years been acquiring companies to fulfill its longterm strategy. If CBAI.OB is a part of that strategy we will learn soon enough because the hospital will soon be storing cord to treat its sick patients. Is CBAI.OB current staffing suitable for treating patients at HQ like a walkin clinic? No, but they might be close to those levels according to the Hospitals of Todays SEC filing describing what it considers a treatment lab will be. HOTI spent a lot of money on the patents Corcell is listed in. Either way its an ad tool we should be capitalizing off of today. Corcell is in Regenetech's patent for bioreactor expansion as a participant in the original experiment. Why is it a whisper here and not advertised on Corcell's website as an accomplishment? Maybe we learn something soon why it's not a marketing tool and I hope it is by design and not an oversite. Also worth mentioning the FDA certificate has been changed from Cord Blood America to Corcell Companies: